Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (461-470 of 903) with videos related to

Pageof 91
Sort By:
Annals of Neurology|September 10, 2018
Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological ChangesInge M W Verberk, Rosalinde E Slot, Sander C J Verfaillie, et al.
Current Alzheimer Research|December 20, 2014
Predicting progression from cognitive impairment to Alzheimer's disease with the Disease State IndexAnette Hall, Jussi Mattila, Juha Koikkalainen, et al.
Annals of Clinical and Translational Neurology|January 9, 2021
Amyloid-β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest-oldWiesje Pelkmans, Nienke Legdeur, Mara Ten Kate, et al.
EMBO Molecular Medicine|July 13, 2021
Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkersRik Ossenkoppele, Juhan Reimand, Ruben Smith, et al.
Journal of Alzheimer'S Disease : JAD|July 25, 2018
Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral AmyloidomaColin Groot, Nelleke Tolboom, Milos D Ikonomovic, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 10, 2016
A novel CCM2 variant in a family with non-progressive cognitive complaints and cerebral microbleedsPetra E Cohn-Hokke, Henne Holstege, Marjan M Weiss, et al.
Stroke|September 6, 2005
Small vessel disease and general cognitive function in nondisabled elderly: the LADIS studyWiesje M van der Flier, Elizabeth C W van Straaten, Frederik Barkhof, et al.
Neurology|October 21, 2018
Clinical phenotype, atrophy, and small vessel disease in <i>APOE</i>ε2 carriers with Alzheimer diseaseColin Groot, Carole H Sudre, Frederik Barkhof, et al.
Alzheimer'S Research & Therapy|October 12, 2021
Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6Andrea Brioschi Guevara, Melanie Bieler, Daniele Altomare, et al.
Neurobiology of Aging|September 11, 2019
Cerebral amyloid burden is associated with white matter hyperintensity location in specific posterior white matter regionsNick A Weaver, Thomas Doeven, Frederik Barkhof, et al.
Pageof 91

Showing results (461-470 of 903) with videos related to

Sort By:
Pageof 91
Annals of Neurology|September 10, 2018
Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological ChangesInge M W Verberk, Rosalinde E Slot, Sander C J Verfaillie, et al.
Current Alzheimer Research|December 20, 2014
Predicting progression from cognitive impairment to Alzheimer's disease with the Disease State IndexAnette Hall, Jussi Mattila, Juha Koikkalainen, et al.
Annals of Clinical and Translational Neurology|January 9, 2021
Amyloid-β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest-oldWiesje Pelkmans, Nienke Legdeur, Mara Ten Kate, et al.
EMBO Molecular Medicine|July 13, 2021
Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkersRik Ossenkoppele, Juhan Reimand, Ruben Smith, et al.
Journal of Alzheimer'S Disease : JAD|July 25, 2018
Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral AmyloidomaColin Groot, Nelleke Tolboom, Milos D Ikonomovic, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 10, 2016
A novel CCM2 variant in a family with non-progressive cognitive complaints and cerebral microbleedsPetra E Cohn-Hokke, Henne Holstege, Marjan M Weiss, et al.
Stroke|September 6, 2005
Small vessel disease and general cognitive function in nondisabled elderly: the LADIS studyWiesje M van der Flier, Elizabeth C W van Straaten, Frederik Barkhof, et al.
Neurology|October 21, 2018
Clinical phenotype, atrophy, and small vessel disease in <i>APOE</i>ε2 carriers with Alzheimer diseaseColin Groot, Carole H Sudre, Frederik Barkhof, et al.
Alzheimer'S Research & Therapy|October 12, 2021
Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6Andrea Brioschi Guevara, Melanie Bieler, Daniele Altomare, et al.
Neurobiology of Aging|September 11, 2019
Cerebral amyloid burden is associated with white matter hyperintensity location in specific posterior white matter regionsNick A Weaver, Thomas Doeven, Frederik Barkhof, et al.
Pageof 91